Cargando…
Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic
Coronaviruses are pleomorphic, enveloped, or spherical viruses, which have a size ranging from 80 to 120 nm. These viruses act on receptors that cause the triggering of fusion. Coronaviruses were first described after cultivation from patients with common colds by Tyrell and Bynoe in 1966. There are...
Autores principales: | Bhandari, Ranjana, Khanna, Garima, Kuhad, Anurag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550915/ https://www.ncbi.nlm.nih.gov/pubmed/33065092 http://dx.doi.org/10.1016/j.ejphar.2020.173643 |
Ejemplares similares
-
Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19
por: Bhandari, Ranjana, et al.
Publicado: (2021) -
Taurine as a potential therapeutic agent interacting with multiple signaling pathways implicated in autism spectrum disorder (ASD): An in-silico analysis
por: Bhandari, Ranjana, et al.
Publicado: (2023) -
PM345. Resveratrol Suppresses Neuroinflammation in the Experimental Paradigm of Autism Spectrum Disorders
por: Bhandari, Ranjana, et al.
Publicado: (2016) -
Novel Nanotechnological Approaches for Targeting Dorsal Root Ganglion (DRG) in Mitigating Diabetic Neuropathic Pain (DNP)
por: Bhandari, Ranjana, et al.
Publicado: (2022) -
COVID-19 associated complications and potential therapeutic targets
por: Monpara, Jasmin D., et al.
Publicado: (2020)